Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Acta Medica Colombiana
Print version ISSN 0120-2448
Abstract
RENDON, Iván Darío et al. Restrictive cardiomyopathy as a presentation of amyloidosis. Acta Med Colomb [online]. 2010, vol.35, n.3, pp.126-131. ISSN 0120-2448.
Cardiac amyloidosis is a rare disease that may occur as a component of systemic amyloidosis. Its symptomatic phase usually presents when cardiac function is highly compromised. Recently, some non-invasive diagnostic tools have emerged improving diagnosis. Treatment for this disease depends on its subtype. In most cases, it consists on supportive measures to improve heart failure and organ function, in addition with oral chemotherapy and autologous stem-cell transplantation. Alongside, new prognostic factors have been introduced. As an example, a clinical case about a patient who develops rapid-progression dyspnea and congestive heart failure is described. The ecocardiographic report stated a left ventricular concentric hypertrophy and ecogenic infiltrate patterns associated with extensive fibrosis. This leaded to the diagnosis of cardiac amyloidosis secondary to systemic amyloidosis. Based on this case, characteristics and new advances in its management are presented (Acta Med Colomb 2010; 35: 126-131).
Keywords : amyloidosis; restrictive cardiopathy; diagnosis; management.